2013
DOI: 10.1016/j.sbi.2013.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Are predicted protein structures of any value for binding site prediction and virtual ligand screening?

Abstract: The recently developed field of ligand homology modeling, LHM, that extends the ideas of protein homology modeling to the prediction of ligand binding sites and for use in virtual ligand screening has emerged as a powerful new approach. Unlike traditional docking methodologies, LHM can be applied to low-to-moderate resolution predicted as well as experimental structures with little if any diminution in performance; thereby enabling ~75% of an average proteome to have potentially significant virtual screening p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 68 publications
(103 reference statements)
0
15
0
Order By: Relevance
“…The usefulness of homology models in structure based virtual screening has been demonstrated in various retrospective analyses on a broad variety of different targets (Costanzi, 2013; Kairys et al, 2006; McGovern and Shoichet, 2003; Oshiro et al, 2004; Skolnick et al, 2013). One class of proteins with particular interest for structure based drug discovery are GPCRs, where recent advances in experimental structure determination have brought a wide range of receptors within range for comparative modeling techniques (Carlsson et al, 2011; Kobilka and Schertler, 2008).…”
Section: Application Of Homology Models In Structure-based Drug Discomentioning
confidence: 99%
“…The usefulness of homology models in structure based virtual screening has been demonstrated in various retrospective analyses on a broad variety of different targets (Costanzi, 2013; Kairys et al, 2006; McGovern and Shoichet, 2003; Oshiro et al, 2004; Skolnick et al, 2013). One class of proteins with particular interest for structure based drug discovery are GPCRs, where recent advances in experimental structure determination have brought a wide range of receptors within range for comparative modeling techniques (Carlsson et al, 2011; Kobilka and Schertler, 2008).…”
Section: Application Of Homology Models In Structure-based Drug Discomentioning
confidence: 99%
“…An important question asked by protein modelers, and biological researchers in general, is: what kind of structural information can be obtained from the docking of protein models and what is the reliability of such predictions? Protein models were shown to have significant utility in studies of protein–ligand interactions and characterization of functional sites . Protein–protein docking of models by information driven approach was validated on a set of CAPRI targets .…”
Section: Introductionmentioning
confidence: 99%
“…Protein models were shown to have significant utility in studies of protein-ligand interactions and characterization of functional sites. [13][14][15] Protein-protein docking of models by information driven approach was validated on a set of CAPRI targets. 16 High-resolution free docking was recently tested on a diverse set of protein models to reveal that meaningful predictions can be obtained even for models with significant distortions, although at significantly lower success rates.…”
Section: Introductionmentioning
confidence: 99%
“…However, this situation is changing and homology modeling is currently making structural information available for large numbers of proteins [3]. Moreover, it has been shown that modeled proteins can be effectively used to annotate function [4,5,6,7]. …”
Section: Introductionmentioning
confidence: 99%